David C. Demoise

David Demoise practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

David Demoise's NPI, 1174623656, was assigned on September 24, 2006. David Demoise graduated from Perelman School of Med at the University of Pennsylvania in 1997. David Demoise holds Pennsylvania license MD434584.

David Demoise's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

David Demoise's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. David Demoise is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links David Demoise to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where David Demoise practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is David Demoise's primary specialty in the NPI Registry, under taxonomy code 207R00000X. David Demoise is board certified in internal medicine by the American Board of Internal Medicine. David Demoise is licensed in Pennsylvania.

CMS data shows 204 Medicare services from David Demoise across 5 procedure codes in 2024, for 100 Medicare patients. Medicare paid $12,212 for them.

CMS counts 100 Medicare patients who saw David Demoise in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts David Demoise's median patient age at 72, with 38% women.

In 2024, David Demoise wrote 4,797 Medicare Part D claims for 390 patients. 84% of them were for generic drugs. CMS names the drug for 4,267 of them, across 87 drugs with 11 or more claims each, at $423,417 in total drug cost. In 2023, CMS named 3,834 claims across 85 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for David Demoise for performance year 2024, reported as part of a group. David Demoise accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists David Demoise as offering telehealth.

Dmand AI links 1 paper to David Demoise in 2019. David Demoise's most frequent co-authors are Jaishree Hariharan, Erika L. Hoffman, MD and Amar R. Kohli.

David Demoise graduated from Perelman School of Med at the University of Pennsylvania in 1997.